PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,764,000 | +22082.9% | 1,501,699 | +10979.4% | 0.00% | – |
Q1 2021 | $35,000 | +29.6% | 13,554 | +24.3% | 0.00% | – |
Q4 2020 | $27,000 | -94.7% | 10,905 | -92.7% | 0.00% | – |
Q3 2019 | $513,000 | +1408.8% | 150,364 | +1071.9% | 0.00% | – |
Q4 2018 | $34,000 | -52.1% | 12,831 | +0.8% | 0.00% | – |
Q3 2018 | $71,000 | -64.3% | 12,732 | -67.7% | 0.00% | – |
Q2 2018 | $199,000 | -75.5% | 39,392 | -66.9% | 0.00% | – |
Q1 2018 | $812,000 | – | 119,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
Annandale Capital, LLC | 67,000 | $70 | 0.02% |
WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
Sigma Planning Corp | 343,934 | $357,691 | 0.01% |